STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib

• Misako Nagasaka, MD,
• Nagaratna Sarvadevabatla, MD,
• Shawn Iwata, BSN,
• Yubin Ge, PhD,
• Ammar Sukari, MD,
• Christian Klosowski, MS,
• Ronald Yanagihara, MD

Affiliations

Misako Nagasaka, MD

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan; Corresponding author. Address for correspondence: Misako Nagasaka, MD, Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R, Detroit, MI 48201.

Nagaratna Sarvadevabatla, MD

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

Shawn Iwata, BSN

Hematology/Oncology, Straub Clinic, Honolulu, Hawaii

Yubin Ge, PhD

Department of Oncology, Wayne State University, Detroit, Michigan

Ammar Sukari, MD

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

Christian Klosowski, MS

Guardant Health, Redwood City, California

Ronald Yanagihara, MD

Hematology/Oncology, Straub Clinic, Honolulu, Hawaii